ArticleScientific reports2025
ToxIR: an accurate RNA-seq pipeline for high-precision toxin transcriptome profiling, validated in odontobuthus doriae venom glands.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Transcriptome analysis of complex tissues remains challenging due to assembly errors, isoform diversity, and annotation bias, necessitating optimized computational pipelines. Scorpion venoms are a treasure trove of bioactive peptides with significant biomedical potential, but their complexity complicates transcriptome profiling. We present ToxIR (Toxin Identification and Recognition), an RNA-seq pipeline optimized for accurate toxin transcriptome analysis, validated in Odontobuthus doriae venom glands. ToxIR combines deep sequencing, rnaSPAdes based de novo assembly, and a tailored annotation strategy to detect even low-abundance toxins and resolve isoforms with high accuracy. It incorporates rigorous quality control (FastQC, Trimmomatic), curated UniProt toxin homology searches, and integrated structural analyses (SignalP, TMHMM, Pfam, InterProScan) to prioritize candidates based on signal peptides, cysteine content, and toxin-specific domains. Unlike general-purpose or previous toxin pipelines, ToxIR minimizes misassemblies and annotation bias through its modular design, automated structural queries, and SQLite-backed data integration. The pipeline identified 378 putative toxin candidates, including 192 high-confidence candidates (Group A) and 23 novel, divergent toxins (Group C). These included 180 sodium channels, 111 potassium channels, and 69 chloride channel toxins. By enabling flexible cross-species use and enhancing annotation precision, ToxIR provides a robust framework that accelerates the discovery of therapeutic toxins.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.